MOGUT (COENBIO CO., LTD.)


Welcome to the PulseAid listing for the MOGUT drug offered from COENBIO CO., LTD.. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: COENBIO CO., LTD.
NON-PROPRIETARY NAME: Lactobacillus fermentum, Lactobacillus sakei, Leuconostoc holzapfelii, Leuconostoc mesenteroides, Enterococcus faecium
SUBSTANCE NAME: LACTOBACILLUS REUTERI; ENTEROCOCCUS FAECIUM
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2017-08-01
END MARKETING DATE: 0000-00-00


MOGUT HUMAN OTC DRUG Details:

Item DescriptionMOGUT from COENBIO CO., LTD.
LABELER NAME: COENBIO CO., LTD.
DEA SCHEDULE:
ACTIVE STRENGTH: 20; 20(g/100mL; g/100mL)
START MARKETING DATE: 2017-08-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 71682-0001_57ca4c0b-1cea-13bd-e053-2991aa0a6d8d
PRODUCT NDC: 71682-0001
APPLICATION NUMBER:

Other LACTOBACILLUS REUTERI; ENTEROCOCCUS FAECIUM Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
COENBIO CO., LTD.MOGUT